9.675
price up icon5.13%   0.475
 
loading
前日終値:
$9.20
開ける:
$9.38
24時間の取引高:
4,138
Relative Volume:
0.00
時価総額:
$688.65M
収益:
$133.62M
当期純損益:
$-177.37M
株価収益率:
-3.3478
EPS:
-2.89
ネットキャッシュフロー:
$23.50M
1週間 パフォーマンス:
+9.54%
1か月 パフォーマンス:
+15.01%
6か月 パフォーマンス:
-52.73%
1年 パフォーマンス:
-51.18%
1日の値動き範囲:
Value
$9.21
$10.06
1週間の範囲:
Value
$8.83
$10.06
52週間の値動き範囲:
Value
$7.16
$27.24

Xencor Inc Stock (XNCR) Company Profile

Name
名前
Xencor Inc
Name
セクター
Healthcare (1166)
Name
電話
626-305-5900
Name
住所
465 N. HALSTEAD ST., PASADENA, CA
Name
職員
250
Name
Twitter
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
XNCR's Discussions on Twitter

XNCR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
XNCR
Xencor Inc
9.676 600.68M 133.62M -177.37M 23.50M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.32 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.31 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.53 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
569.13 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.48 29.19B 3.81B -644.79M -669.77M -6.24

Xencor Inc Stock (XNCR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-21 開始されました William Blair Outperform
2024-12-12 開始されました Wells Fargo Overweight
2024-12-02 アップグレード Piper Sandler Neutral → Overweight
2024-04-16 繰り返されました BTIG Research Buy
2024-02-28 ダウングレード Piper Sandler Overweight → Neutral
2023-05-19 開始されました BofA Securities Buy
2022-12-06 開始されました Cowen Outperform
2022-10-13 アップグレード Raymond James Outperform → Strong Buy
2022-09-21 開始されました JP Morgan Overweight
2022-07-06 再開されました Canaccord Genuity Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-01-21 開始されました SMBC Nikko Outperform
2021-12-15 開始されました H.C. Wainwright Buy
2021-10-15 再開されました BTIG Research Buy
2021-02-24 アップグレード Raymond James Mkt Perform → Outperform
2020-03-04 開始されました Barclays Underweight
2020-02-25 アップグレード Guggenheim Neutral → Buy
2020-01-30 開始されました RBC Capital Mkts Outperform
2019-11-20 再開されました Guggenheim Neutral
2019-08-07 ダウングレード Guggenheim Buy → Neutral
2019-08-07 ダウングレード Raymond James Outperform → Mkt Perform
2019-06-13 開始されました Mizuho Buy
2019-04-12 開始されました Guggenheim Buy
2019-03-27 開始されました Berenberg Buy
2019-03-15 開始されました Raymond James Outperform
2018-09-10 再開されました BTIG Research Buy
2018-03-28 再開されました Leerink Partners Outperform
2017-03-02 開始されました Instinet Neutral
2017-03-02 繰り返されました Wedbush Outperform
2016-10-04 開始されました Piper Jaffray Overweight
2015-12-22 開始されました Canaccord Genuity Buy
2015-08-05 繰り返されました MLV & Co Buy
2015-02-12 繰り返されました Oppenheimer Outperform
2015-01-28 繰り返されました MLV & Co Buy
2014-07-11 開始されました Oppenheimer Outperform
すべてを表示

Xencor Inc (XNCR) 最新ニュース

pulisher
11:30 AM

Is Xencor Inc. a good long term investmentFree Investment Case Studies - Autocar Professional

11:30 AM
pulisher
07:37 AM

What analysts say about Xencor Inc. stockConsistent high-yield stocks - Autocar Professional

07:37 AM
pulisher
03:53 AM

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Arizona State Retirement System - Defense World

03:53 AM
pulisher
Jul 22, 2025

What drives Xencor Inc. stock priceFree Stock Market Query - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Xencor Inc. Stock Analysis and ForecastMarket-beating performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Xencor Inc. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Teacher Retirement System of Texas - Defense World

Jul 21, 2025
pulisher
Jul 19, 2025

Where are the Opportunities in (XNCR) - news.stocktradersdaily.com

Jul 19, 2025
pulisher
Jul 19, 2025

What risks could impact Xencor Inc. stock performanceVerified Return Tips - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

Principal Financial Group Inc. Grows Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Jul 18, 2025
pulisher
Jul 17, 2025

Xencor’s Phase 2 Study on Vudalimab in Prostate Cancer: Key Update and Market Impact - TipRanks

Jul 17, 2025
pulisher
Jul 16, 2025

[Latest] Global Ultomiris Drug Market Size/Share Worth USD 64.12 Billion by 2034 at a 31.52% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.

Jul 16, 2025
pulisher
Jul 15, 2025

How Xencor Inc. stock performs during market volatilityFree Financial Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Xencor Inc. stock price move sharplyLow Volatility High Yield Stocks - Newser

Jul 15, 2025
pulisher
Jul 03, 2025

Xencor, Inc. (NASDAQ:XNCR) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jul 03, 2025
pulisher
Jul 01, 2025

Fed. Circ. Won't Revisit Jepson Claim Ruling In Xencor IP Case - Law360

Jul 01, 2025
pulisher
Jun 28, 2025

(XNCR) Investment Analysis - news.stocktradersdaily.com

Jun 28, 2025
pulisher
Jun 18, 2025

Closing Figures Unveiled: Xencor Inc (XNCR) Drop -8.18, Closes at 8.31 - DWinneX

Jun 18, 2025
pulisher
Jun 18, 2025

Rhumbline Advisers Has $1.74 Million Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

Xencor (NASDAQ:XNCR) Shares Down 5.7% on Insider Selling - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

(XNCR) On The My Stocks Page - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 17, 2025

Xencor director Gustafson sells shares worth $27,595 - Investing.com Australia

Jun 17, 2025
pulisher
Jun 16, 2025

Xencor director Montgomery sells shares worth $20,422 - Investing.com

Jun 16, 2025
pulisher
Jun 13, 2025

Xencor Holds Annual Stockholders Meeting on June 12 - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Xencor (NASDAQ:XNCR) Trading Up 6.3%Should You Buy? - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

USPTO Tells Fed. Circ. Not To Review Ruling In Xencor Case - Law360

Jun 12, 2025
pulisher
Jun 11, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Jun 11, 2025
pulisher
Jun 10, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Purchased by California State Teachers Retirement System - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Bank of America Corp DE Sells 585,930 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

27,491 Shares in Xencor, Inc. (NASDAQ:XNCR) Acquired by Wellington Management Group LLP - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

When (XNCR) Moves Investors should Listen - news.stocktradersdaily.com

Jun 05, 2025
pulisher
May 30, 2025

Xencor Inc (NASDAQ: XNCR) Jumps 2.45%: What Could Be On The Way Going Forward? - Stocksregister

May 30, 2025
pulisher
May 30, 2025

Xencor, Inc. (XNCR) Stock Analysis: Exploring a Biotechnology Innovator with 264.58% Potential Upside - DirectorsTalk Interviews

May 30, 2025
pulisher
May 28, 2025

Xencor’s SWOT analysis: biotech stock faces pivotal year amid pipeline progress - Investing.com Nigeria

May 28, 2025

Xencor Inc (XNCR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Xencor Inc (XNCR) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
GUSTAFSON KURT A
Director
Jun 16 '25
Sale
9.22
2,993
27,595
20,183
GORMAN KEVIN CHARLES
Director
Jun 16 '25
Sale
9.22
3,173
29,255
18,905
Feigal Ellen
Director
Jun 16 '25
Sale
9.22
2,993
27,595
19,183
RANIERI RICHARD J
Director
Jun 16 '25
Sale
9.22
2,993
27,595
19,183
$22.79
price up icon 4.47%
$35.94
price down icon 0.44%
$102.92
price down icon 0.07%
$27.60
price up icon 4.07%
$113.60
price up icon 1.92%
biotechnology ONC
$295.19
price down icon 0.15%
大文字化:     |  ボリューム (24 時間):